EUVIMEDDécouvrir EUVIMED
Open access · CC BY-NC 4.0

Five years of nationwide use of whole genome sequencing in ongoing pregnancies: Diagnostic yield, timing, and implementation

Ida Vogel iD, Lotte Andreasen iD, Pernille Mathiesen Tørring iD, Marie Skov Hvidbjerg iD, Martin Larsen iD, Ida Charlotte Bay Lund iD, Laura Kirstine Sønderberg Roos iD, Katrine Saldern Aagaard iD, Karina Hjort-Pedersen iD, Lene Sperling iD, Pernille Marker Rydder iD, Eva Hoseth iD and 13 more

Acta Obstetricia et Gynecologica Scandinavica · 2026-11-11

DOI: 10.1111/aogs.70384 ↗

At a glance

Journal article in Acta Obstetricia et Gynecologica Scandinavica, published online on 2026-11-11. Written by Ida Vogel and 24 co-authors. Institution: Department of Clinical Medicine, Aarhus University, Aarhus, Denmark. 20 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: Novo Nordisk Fonden, Danmarks Frie Forskningsfond.

RésuméSubjectsRéférences bibliographiquesCiteRelated studies

Abstract (original language)

Introduction

We describe timing, diagnostic yield, secondary findings of prenatal whole genome sequencing (pWGS) in ongoing pregnancies during the first 5 years of implementation within a publicly funded healthcare system. Moreover, we discuss our collective clinical experiences implementing pWGS in prenatal care. Material and Methods We conducted a historical cohort study, including all singleton pregnancies undergoing pWGS after a normal chromosomal microarray between 2019 and 2023. Data on sample type, gestational age at test ordering, turnaround time, diagnostic yield, and secondary findings were extracted from all four Danish clinical genetics laboratories.

Results

A total of 207 cases were analyzed, including 85 chorionic villus samples and 122 amniotic fluid samples; trio sequencing was performed in 204/207 (98.6%). Median gestational age at ordering was 20 weeks (IQR 17–21). Median turnaround time for ongoing pregnancies was 11 working days (IQR 8–17). Pathogenic or likely pathogenic variants explaining the phenotype were identified in 33/207 pregnancies (15.9%, 95% CI 11.6–21.5). Yield was highest in hydrops (25.0%, 95% CI 12.0–44.9) and multiple anomalies (24.3%, 95% CI 13.4–40.1), and lowest in isolated increased nuchal translucency (7.1%, 95% CI 2.0–22.6). Secondary findings were reported in 18/207 cases (8.7%, 95% CI 5.6–13.3). Conclusions pWGS was delivered within clinically relevant turnaround times. Applied after normal chromosomal microarray, the yield represents incremental diagnostic value in a chromosomal microarray‐negative population. In clinical practice, both normal and abnormal pWGS results form a central component of counseling in ongoing pregnancies with unresolved fetal risk. However, the impact of such results on parental decision‐making or pregnancy outcomes was not assessed in this study.

Subjects

Author keywords

Denmarkclinical guidelinesdiagnostic yieldgenomic medicineprenatal diagnosticsprenatal screening and diagnostic technologiespublic healthcare systemwhole genome sequencing

Authors and institutions

  • Department of Clinical Medicine, Aarhus University, Aarhus, Denmark.
  • Department of Clinical Medicine, Centre for Fetal Diagnostics, Aarhus University, Aarhus, Denmark.
  • Department of Obstetrics and Gynaecology, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.
  • Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.
  • Centre for Fetal Genetics, Region of Southern Denmark, Odense, Denmark.

ORCID profiles: Ida Vogel, Lotte Andreasen, Pernille Mathiesen Tørring, Marie Skov Hvidbjerg, Martin Larsen, Ida Charlotte Bay Lund, Laura Kirstine Sønderberg Roos, Katrine Saldern Aagaard, Karina Hjort-Pedersen, Lene Sperling, Pernille Marker Rydder, Eva Hoseth, Stina Lou, Lone Sunde, Olav Bjørn Petersen, Finn Stener Jørgensen, Sidsel Barken, Kathinka Marie Hoff Nyborg, Louise Hornstrup, Cathrine Vedel, Marie Balslev-Harder, Tina Duelund Hjortshøj

Funding

  • Novo Nordisk Fonden
  • Danmarks Frie Forskningsfond

Cite

APA

Vogel, I., Andreasen, L., Tørring, P. M., Hvidbjerg, M. S., Larsen, M., Lund, I. C. B., Roos, L. K. S., Aagaard, K. S., Hjort-Pedersen, K., Sperling, L., Rydder, P. M., Hoseth, E., Lou, S., Sunde, L., Petersen, O. B., Sandager, P., Jørgensen, F. S., Barken, S., Roslev, A. C., …, & Becher, N. (2026). Five years of nationwide use of whole genome sequencing in ongoing pregnancies: Diagnostic yield, timing, and implementation. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70384

Vancouver

Vogel I, Andreasen L, Tørring PM, Hvidbjerg MS, Larsen M, Lund ICB, et al. Five years of nationwide use of whole genome sequencing in ongoing pregnancies: Diagnostic yield, timing, and implementation. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70384

BibTeX
@article{Vogel2026,
  author = {Vogel, Ida and Andreasen, Lotte and Tørring, Pernille Mathiesen and Hvidbjerg, Marie Skov and Larsen, Martin and Lund, Ida Charlotte Bay and Roos, Laura Kirstine Sønderberg and Aagaard, Katrine Saldern and Hjort-Pedersen, Karina and Sperling, Lene and Rydder, Pernille Marker and Hoseth, Eva and Lou, Stina and Sunde, Lone and Petersen, Olav Bjørn and Sandager, Puk and Jørgensen, Finn Stener and Barken, Sidsel and Roslev, Anne Cathrine and Nyborg, Kathinka Marie Hoff and Hornstrup, Louise and Vedel, Cathrine and Balslev-Harder, Marie and Hjortshøj, Tina Duelund and Becher, Naja},
  title = {Five years of nationwide use of whole genome sequencing in ongoing pregnancies: Diagnostic yield, timing, and implementation},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  doi = {10.1111/aogs.70384}
}
Start for free →